| Date Filed | Type | Description |
| 08/10/2023 |
4
| Obenshain Andrew (President and CEO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 16,929 shares
@ $3.5416, valued at
$60k
|
|
| 06/06/2023 |
4
| Klima Thomas J (See Remarks) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 4,130 shares
@ $3.499, valued at
$14.5k
|
|
| 04/05/2023 |
3
| Paulson Richard A. (Director) has filed a Form 3 on bluebird bio, Inc. |
| 04/05/2023 |
4
| Paulson Richard A. (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 4,663 shares
@ $0
Granted 7,500 options to buy
@ $3.3, valued at
$24.8k
|
|
| 03/09/2023 |
4
| Leiderman Elisabeth (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 1,004 shares
@ $6.4643, valued at
$6.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
4
| Obenshain Andrew (President and CEO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 3,178 shares
@ $7.8043, valued at
$24.8k
|
|
| 01/13/2023 |
4
| Colvin Richard A (Chief Medical Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 557 shares
@ $7.8043, valued at
$4.3k
|
|
| 01/13/2023 |
4
| Leschly Nick (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 4,290 shares
@ $7.8043, valued at
$33.5k
|
|
| 01/09/2023 |
3
| Vittiglio Joseph (Chief Business & Legal Officer) has filed a Form 3 on bluebird bio, Inc. |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2022 |
3
| Krawtschuk Christopher (CFO) has filed a Form 3 on bluebird bio, Inc. |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| Klima Thomas J (See Remarks) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 11,000 shares
@ $0
Granted 22,000 options to buy
@ $6.55, valued at
$144.1k
|
|
| 08/25/2022 |
3
| Colvin Richard A (Chief Medical Officer) has filed a Form 3 on bluebird bio, Inc. |
| 08/23/2022 |
4
| Cole Jason (Chief Strategy & Financial Off) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 14,194 shares
@ $5.5286, valued at
$78.5k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Obenshain Andrew (President and CEO) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 21,805 shares
@ $4.3914, valued at
$95.8k
|
|
| 07/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Leschly Nick (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 3,109 shares
@ $0
Granted 5,000 options to buy
@ $4.46, valued at
$22.3k
|
|
| 06/23/2022 |
4
| Vachon Mark (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 4,353 shares
@ $0
Granted 7,000 options to buy
@ $4.46, valued at
$31.2k
|
|
| 06/23/2022 |
4
| Agwunobi John O (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 3,109 shares
@ $0
Granted 5,000 options to buy
@ $4.46, valued at
$22.3k
|
|
| 06/23/2022 |
4
| Leiderman Elisabeth (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 3,109 shares
@ $0
Granted 5,000 options to buy
@ $4.46, valued at
$22.3k
|
|
| 06/23/2022 |
4
| Tita-Reid Najoh (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 3,109 shares
@ $0
Granted 5,000 options to buy
@ $4.46, valued at
$22.3k
|
|
| 06/07/2022 |
4
| Klima Thomas J (Chief Commercial Officer) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Sold 3,753 shares
@ $3.0736, valued at
$11.5k
|
|
| 03/09/2022 |
4
| Jones-Burton Charlotte (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 4,663 shares
@ $0
Granted 7,500 options to buy
@ $4.45, valued at
$33.4k
|
|
| 03/09/2022 |
3
| Jones-Burton Charlotte (Director) has filed a Form 3 on bluebird bio, Inc. |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|